CoChat

Use of amyloid-PET to determine cutpoints for CSF markers: A multicenter study

Open access
Zwan, Marissa D., Rinne, Juha O., Hasselbalch, Steen G., Nordberg, Agneta, Lleó, Alberto, Herukka, Sanna-Kaisa, Soininen, Hilkka, Law, Ian, Bahl, Justyna M.C., Carter, Stephen F., Fortea, Juan, Blesa, Rafael, Teunissen, Charlotte E., Bouwman, Femke H., van Berckel, Bart N.M., Visser, Pieter J. · 2016 · Neurology
Cited by 66

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

OBJECTIVES: To define CSF β-amyloid 1-42 (Aβ42) cutpoints to detect cortical amyloid deposition as assessed by 11C-Pittsburgh compound B ([11C]PiB)-PET and to compare these calculated cutpoints with cutpoints currently used in clinical practice. METHODS: We included 433 participants (57 controls, 99 with mild cognitive impairment, 195 with Alzheimer disease [AD] dementia, and 82 with non-AD dementia) from 5 European centers. We calculated for each center and for the pooled cohort CSF Aβ42 and Aβ42/tau ratio cutpoints for cortical amyloid deposition based on visual interpretation of [11C]PiB-PET images. RESULTS: Amyloid-PET-based calculated CSF Aβ42 cutpoints ranged from 521 to 616 pg/mL, whereas existing clinical-based cutpoints ranged from 400 to 550 pg/mL. Using the calculated cutpoint from the pooled sample (557 pg/mL), concordance between CSF Aβ42 and amyloid-PET was 84%. Similar concordance was found when using a dichotomized Aβ42/tau ratio. Exploratory analysis showed that participants with a positive amyloid-PET and normal CSF Aβ42 levels had higher CSF tau and phosphorylated tau levels and more often had mild cognitive impairment or AD dementia compared with participants who had negative amyloid-PET and abnormal CSF Aβ42 levels. CONCLUSIONS: Amyloid-PET-based CSF Aβ42 cutpoints were higher and tended to reduce intercenter variability compared with clinical-based cutpoints. Discordant participants with normal CSF Aβ42 and a positive amyloid-PET may be more likely to have AD-related amyloid pathology than participants with abnormal CSF Aβ42 and a negative amyloid-PET. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that an amyloid-PET-based CSF Aβ42 cutpoint identifies individuals with amyloid deposition with a sensitivity of 87% and specificity of 80%.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000002081

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 66

Metadata

Authors
Zwan, M. D., Rinne, J. O., Hasselbalch, S. G., Nordberg, A., Lleó, A., Herukka, S.-K., Soininen, H., Law, I., Bahl, J. M. C., Carter, S. F., Fortea, J., Blesa, R., Teunissen, C. E., Bouwman, F. H., van Berckel, B. N. M., & Visser, P. J.
Venue
Neurology
Published
2016-01-05
Volume
86
Issue
1
Pages
50-58
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2213841503
Cited by
66
References
12
FWCI
6.75
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Use of amyloid-PET to determine cutpoints for CSF markers: A multicenter study. https://app.cochat.ai/papers/10.1212/wnl.0000000000002081
The paper
Zwan, M. D., Rinne, J. O., Hasselbalch, S. G., Nordberg, A., Lleó, A., Herukka, S.-K., Soininen, H., Law, I., Bahl, J. M. C., Carter, S. F., Fortea, J., Blesa, R., Teunissen, C. E., Bouwman, F. H., van Berckel, B. N. M., & Visser, P. J. (2016). Use of amyloid-PET to determine cutpoints for CSF markers: A multicenter study. Neurology. https://doi.org/10.1212/wnl.0000000000002081

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.